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We investigated whether dietary intakes of total fat, monounsaturated fat (MUFA), polyunsaturated fat (PUFA) and saturated fat
(SFA) were associated with breast cancer risk in a prospective cohort of 49261 Swedish women (30–49 years at enrolment), which
yielded 974 breast cancer cases by December 2005. Further, we evaluated if associations differed by oestrogen and/or progesterone
receptor tumour status. Total fat, MUFA, PUFA or SFA were not associated with risk overall. However, women in the highest MUFA
and PUFA quintile intake had a reduced breast cancer risk after age 50 years (hazard ratios: 95% confidence interval¼0.45: 0.25–
0.99 and 0.54: 0.35–0.85, respectively) compared to women in the lowest quintile. The associations did not differ by oestrogen or
progesterone receptor status. Despite the negative findings, type of fat during premenopausal years may have later differential effects
on risk.
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Animal, ecological and some case–control studies suggest that a
high consumption of total dietary fat increases breast cancer risk
(Rose, 1997; Boyd et al, 2003), but results from cohort studies,
mainly in postmenopausal women, are inconsistent (Smith-
Warner et al, 2001; Boyd et al, 2003). Two large prospective US
cohorts of postmenopausal women reported no (Kim et al, 2006)
and a positive (Thiebaut et al, 2007) association. Conflicting
results have also been reported regarding fat subtypes. Olive oil,
rich in monounsaturated fat (MUFA), has been reported to reduce
breast cancer risk in Mediterranean populations (Trichopoulou,
1995). There is another experimental evidence suggesting that
MUFA, especially oleic acid, is protective (Bartsch et al, 1999);
however of the 13 prospective studies only two reported an inverse
association with MUFA intake (Wolk et al, 1998; Voorrips et al,
2002), both mostly of postmenopausal women in North European
populations (Sweden and the Netherlands).
Risk factors may differ by hormone receptor status (Colditz et al,
2004), and an inverse association with fruit and vegetables has been
reported for oestrogen-receptor negative (ER )b u tn o tf o rE R þ
tumours (Fung et al, 2005). Higher fat intake was slightly, but not
significantly, positively associated with ER
þ/PR
þ but negatively with
ER
 /PR
  tumours in postmenopausal women (Kushi et al,1 9 9 5 ) .
Among premenopausal women, stronger positive associations were
reported between animal fat intake and risk of ERþ or PRþ
tumours than with ER  or PR  tumours (Cho et al, 2003). In the
randomised Women’s Health Initiative study, the low-fat group
showed a significantly lower risk of ERþ and PR  breast cancers
(Prentice et al, 2006). In contrast, the associations with fat did not
d i f f e rb yE Ro rP Rs t a t u si nt h eN u r s e s ’H e a l t hS t u d y( K i met al, 2006).
In a prospective cohort study in Swedish women, we
investigated whether intakes of total dietary fat, MUFA, poly-
unsaturated fat (PUFA) and saturated fat (SFA) were associated
with breast cancer risk.
MATERIALS AND METHODS
The study cohort consisted of 49261 women (Kumle et al, 2002).
Briefly, some 96000 women aged 30–49 years (born 1942–1962)
and resident in the Uppsala Health Care Region in 1991–1992 were
randomly selected from four age strata (30–34, 35–39, 40–44 and
45–49 years) and invited to participate in the Swedish component
of the Scandinavian Women’s Lifestyle and Health Cohort.
Around 49261 women returned the study questionnaires and
were enrolled in the study, of whom 9% were postmenopausal.
We excluded 4692 women from the initial cohort due to breast
cancer before enrolment (n¼244), emigration before the follow-
up (n¼7), very high- or low-energy intakes o1 or 99% (n¼1072)
and missing information on BMI, education, use of oral contra-
ceptives (OC), age at menarche, parity, age at first birth or breast
cancer in first-degree relative (mother or sister) (n¼3369). Thus,
the final analysis was conducted on 44569 women. The study was
approved by the ethical committee at the University of Uppsala.
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factors, including average intake of foods and beverages (Lagiou
et al, 2006). Dietary habits during the 6 months preceding
enrolment were ascertained through a validated food-frequency
questionnaire that also covered intake quantity of about 80 food
items and beverages (Wolk et al, 1998). Individual intake of
energy, total fat, MUFA, PUFA, SFA and alcohol were calculated by
linking the amount of foods reported to the National Food
Administration database (1989).
Follow-up was achieved through linking the study database with
nationwide health registers in Sweden using the individually
unique national registration number. From the total population
registers, we received information on the dates of death and
emigration. The national cancer registry, which began in 1958,
identified prevalent cancers at enrolment and on incident cancers
diagnosed during follow-up.
The start of follow-up was defined as the date of return of the
questionnaire. Observation time was calculated from date of entry
into the cohort until the date of breast cancer, emigration, death or
31 December 2005, whichever came first. Oestrogen receptor (ER 
or ERþ) and PR status (PR  or PRþ), determined by means of
an Abbott immunoassay (Pousette et al, 1986), was obtained by
linkage with the regional cancer registry in Uppsala and was
available for cases reported until 31 December 2004.
Statistical analysis
The risk of breast cancer was analysed by fitting of Cox
proportional hazard regression and the corresponding Poisson
models using attained age as time scale (Korn et al, 1997). Hazard
ratios (HRs) were considered significant when the associated two-
sided 95% Wald-type confidence interval (CI) did not include
unity, corresponding to a two-sided 5% level of significance. The
goodness of fit of the different models was compared using the
Akike Information Criteria (AIC).
For total fat, we fitted a model including education categories:
0–10, 11–13, 413 years þ BMI categories: o25, 25–29.9,
X30kg/m
2 þ Parity: 0, 1, 2, 3, X4 þAge at menarche, years þ
use of OC: never, former and current þ Age at first birth, years
(Trichopoulos et al, 1983) þ breast cancer in first-degree relative:
yes or no þ alcohol intake, in g/day þ non-alcohol energy intake,
in kJ/day. Total fat (10g/day) was then added to the model,
alternatively, as: (1) a continuous covariate, (2) in quintiles of total
fat and (3) through splines. The models utilising splines allow for
an informal evaluation of the functional form, for instance if a
linear response function if appropriate. We tested for linear trend
across fat and fat subtype quintiles using the median within each
quintile.
For fat subtypes, we fitted models utilising the linear total fat
model and adding each fat subtype, alternatively, as a linear
continuous variable, as quintiles or as splines. Total fat was
included because it can be a confounder on its own and changes in
one type of fat were expected to reflect changes in the other two
types. We also fitted a model with total unsaturated fat
(MUFAþPUFA) and SFA as continuous linear variables excluding
total fat. We used the standard method for energy adjustment
(Willett et al, 1997). Total fat and fat subtypes were also evaluated
as residuals on non-alcohol energy intake (residual method;
Willett et al, 1997). Because these results were, as expected, similar
compared to those obtained when using the standard model, we
only report results from the latter.
The models above examine the effect of substitution of fat (or fat
subtypes) for carbohydrate or protein (or fat subtype) when non-
alcohol energy intake is held constant. In an additional model, we
also adjusted for protein and carbohydrates by fitting the following
variables: non-nutritional covariates, alcohol, protein, carbohy-
drate, PUFA, MUFA and total fat. It examines the effect of
replacing SFA with PUFA or MUFA while keeping carbohydrate,
protein and total fat (and thus energy) constant. We checked the
proportional hazards assumption by plotting the Schoenfeld
residuals vs time (Grambsch and Therneau, 1994).
We also tested if the associations with total fat, MUFA, PUFA
and SFA differed by ER and PR status. We did not conduct any
analyses with joint ER and PR status because there was a strong
correlation between ER and PR status.
We do not have information about menopausal status after the
start of follow-up. Based on the average age at menopause in
Sweden being 50 years (Weiderpass et al, 1999), the effect of
menopausal status and other risk factors in different periods of life
were evaluated by fitting separate models for breast cancer
occurring before and after the age of 50 years. All statistical
analyses were carried out using the SAS software version 9.1.3
(SAS Institute Inc., Cary, NC, USA) and R version 2.5.0
(www.r-project.org).
RESULTS
The 44569 women were followed for an average of 13 years
yielding a total of 615988 person-years, during which 974 invasive
breast cancers were reported to the cancer registry. The baseline
characteristics for the entire cohort and by quintile of total dietary
fat intake are shown in Table 1. The main food sources of MUFA
were meat (30%), fat for food preparation and sandwiches (20%)
and dairy products (20%). The corresponding figures for SFA were
dairy products (40%), meat (20%) and fat for food preparation and
sandwiches (15%), and for PUFA fat for food preparation and
sandwiches (30%), meat (15%), cereal products (20%) and fish
(7%).
Established non-nutritional risk factors were generally evident
and, for example, parous had a lower risk than nulliparous women
(e.g. parity¼2 vs parity¼0; HR: 0.77, 95% CI: 0.64–0.93), while
having an affected first-degree relative showed an increased risk
(HR: 1.67, 95% CI: 1.33–2.10).
Of the 974 breast cancer cases, 432 occurred before the age
of 50 years. Analysing the time course starting at age 50 years,
14437 women were censored (432 had breast cancer before the age
50 years, 295 died, 527 emigrated and 13183 were too young to
reach the age 50 years at the end of follow up) leaving 30132
women with 542 breast cancer events for the analyses after age 50
years.
Table 2 shows breast cancer risks as HRs with 95% CIs for total
fat, MUFA, PUFA and SFA for the entire cohort as well as before or
after 50 years of age. Total fat intake as a linear continuous
covariate (for a 10g/day increase) or fitted as quintiles was not
associated with overall risk or before or after age 50 years or when
we fitted total fat as splines (data not shown). MUFA, PUFA or SFA
was not associated with risk for the entire cohort nor before 50
years of age, irrespective of the models fitted.
Analysed as a continuous variable, the HR for MUFA intake was
0.55 (95% CI: 0.28–1.09) for a 10g/day increase, while for SFA it
was 1.45 (95% CI: 0.99–2.12), and for PUFA 0.58 (95% CI: 0.32–
1.05) for breast cancer after age 50 years (Table 2). A linear form
for the associations with MUFA, PUFA and SFA was supported by
models using splines.
Compared to women in the first quintile of MUFA intake,
women in the fifth quintile had a statistically significant decreased
breast cancer risk (HR: 0.45; 95% CI: 0.25–0.99) for breast cancer
after 50 years of age. There was a statistically significant trend for a
decreased risk across the quintiles of MUFA intake (P¼0.01).
When the highest PUFA quintile was compared to the lowest, the
HR was 0.54 (95% CI 0.35–0.85). When we finally combined
MUFA and PUFA into unsaturated fat, the HR for breast cancer
was 0.79 (95% CI: 0.62–1.01) for unsaturated fat for a 10g/day
increase and 1.21 (95% CI: 1.00–1.45) for saturated fat for a 10g/day
increase. When we adjusted for protein and carbohydrate in our
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found when replacing SFA with PUFA (HR: 0.64, 95% CI: 0.31–
1.30) or MUFA (HR: 0.62, 95% CI: 0.33–1.16) for a 10g/day
increase.
The point estimates in Table 2 suggest that there is a differential
effect of MUFA, PUFA and SFA intakes on breast cancer risk
occurring before or after 50 years of age. Thus, we also conducted
tests for the interaction between age at diagnosis (o50 vs X50
years) and intake of MUFA, PUFA, SFA as well as unsaturated fat
(PUFAþMUFA). A statistical significant interaction with age at
diagnosis (o50 vs X50 years) was found for intakes of PUFA
(P¼0.049), SFA (P¼0.048) and MUFAþPUFA (P¼0.040), but
not for MUFA (P¼0.116). These results suggest that the effects of
consumption of different types of dietary fat are mainly observed
in breast cancer diagnosed after age 50 years.
Hormone receptor status
For the 974 breast cancer cases, 559 (57%) were ERþ, 160 (17%)
were ER  and 255 (26%) had unknown ER tumour status. With
respect to progesterone receptors, 474 (49%) were PRþ, 235
(24%) PR  and 265 (27%) had unknown PR tumour status. A total
of 94 cases had unknown ER and PR as they were registered during
2005 when no ER/PR status details were available to us. The
distribution of ERþ,E R  ,P R þ and PR  was similar across
MUFA, PUFA, SFA and total fat quintiles.
Overall, compared to women in the first quintile of PUFA intake,
women in the fifth quintile were at a decreased risk of developing
ERþ tumours (HR: 0.60, 95% CI: 0.39 0.92) and PRþ tumours
(HR: 0.59, 95% CI: 0.37 0.95) when considering the entire cohort.
Similar associations were found in the fifth quintile of PUFA intake
Table 1 Baseline characteristics for the entire cohort at enrolment as well as by quintile of total dietary fat intake
Total fat quintiles
Entire cohort 1 2 3 4 5
Characteristics
N 44569 8699 8950 8947 9025 8948
Age, mean±s.d. (years) 39±34 1 ±64 0 ±63 9 ±63 9 ±63 8 ±6
BMI, n (%)(kgm
 2)
o25 32329 (72) 6003 (69) 6347 (71) 6518 (73) 6707 (74) 6754 (75)
25–30 9668 (22) 2129 (24) 2074 (23) 1958 (22) 1817 (20) 1690 (19)
X30 2572 (6) 567 (7) 529 (6) 471 (5) 501 (6) 504 (6)
Education, n (%) (years)
up to 10 13149 (30) 3130 (36) 2824 (32) 2556 (29) 2395 (26) 2244 (25)
11–13 17478 (39) 3144 (36) 3443 (38) 3583 (40) 3660 (41) 3648 (41)
413 13942 (31) 2425 (28) 2683 (30) 2808 (31) 2970 (33) 3056 (34)
Use of oral contraceptives, n (%)
Never 7213 (16) 1467 (17) 1415 (16) 1372 (15) 1423 (16) 1536 (17)
Former 31577 (71) 6220 (71) 6379 (71) 6364 (71) 6433 (71) 6181 (69)
Current 5779 (13) 1012 (12) 1156 (13) 1211 (14) 1169 (13) 1231 (14)
Parity, n (%)
0 6146 (14) 1470 (17) 1279 (14) 1183(13) 1105 (12) 1109 (12)
1 6870(15) 1429 (16) 1421 (16) 1356 (15) 1340 (15) 1324 (15)
2 19328 (43) 3638 (42) 3950 (44) 4001 (45) 3951 (44) 3788 (42)
3 9264 (21) 1615 (19) 1779 (20) 1824 (20) 2009 (22) 2037 (23)
X4 2961 (7) 547 (6) 521 (6) 583 (7) 620 (7) 690 (8)
Alcohol intake, n (%) (g/day)
o5 33338 (74.8) 6591 (75.8) 6746 (75.4) 6605 (73.8) 6705 (74.3) 6691 (74.8)
5–25 11039 (24.8) 2068 (23.8) 2162 (24.1) 2308 (25.8) 2283 (25.3) 2218 (24.8)
425 192 (0.4) 40 (0.4) 42 (0.5) 34(0.4) 37 (0.4) 39 (0.4)
Breast cancer in first-degree relative, n (%)
Yes 2036 (5) 413 (5) 394 (4) 420 (5) 430 (5) 379 (4)
No 42533 (95) 8286 (95) 8556 (96) 8527 (95) 8595 (95) 8569 (96)
Energy, mean±s.d. (kJ/day) 6290±1820 4330±1080 5530±890 6400±890 7320±960 8920±1270
Carbohydrates, mean±s.d.
g/day 189±59 142±48 172±44 195±43 217±47 252±51
% energy 51±16 56±19 53±14 52±11 50±11 48±10
Protein, mean±s.d.
g/day 61±19 43±12 54±11 62±12 70±13 84±16
% energy 16±51 7 ±51 7 ±31 6 ±31 6 ±31 6 ±3
Total fat, mean±s.d. (g/day)
g/day 52±19 29±64 3 ±35 3 ±36 3 ±48 4 ±12
% energy 31±11 25±52 9 ±23 1 ±23 2 ±23 5 ±5
s.d.¼standard deviation. %energy¼percent energy of total energy intake.
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yTable 2 Risk of breast cancer estimated as hazard ratios (HR) with 95% confidence intervals (CIs) for total fat, MUFA, PUFA and SFA for the entire cohort as well as for breast cancers occurring before or
after 50 years of age
Quintiles
Q1 Q2 Q3 Q4 Q5
Trend over
categories (P)
Intake of continuous
form per 10g/day P
Entire cohort
a
Total fat
Median, g/day 30.8 42.9 52.4 63.1 80.7
(% energy) (26) (29) (31) (32) (34)
Cases 208 198 193 206 169
HR (95% CI)
b 1.00 0.99 (0.80–1.22) 1.01 (0.80–1.28) 1.13 (0.86–1.47) 1.02 (0.72–1.45) 0.70 1.04 (0.97–1.11) 0.32
MUFA
Median, g/day 10.4 14.4 17.5 21.0 26.5
(% energy) (9) (10) (10) (11) (11)
Cases 206 202 205 189 172
HR (95% CI)
b 1.00 0.98 (0.79–1.23) 1.01 (0.76–1.33) 0.95 (0.67–1.35) 0.88 (0.53–1.46) 0.65 0.82 (0.49–1.35) 0.43
PUFA
Median, g/day 4.3 6.0 7.3 8.7 11.2
(% energy) (3.6) (4.0) (4.2) (4.4) (4.8)
Cases 209 201 191 205 168
HR (95% CI)
b 1.00 0.93 (0.76–1.14) 0.89 (0.71–1.12) 0.92 (0.71–1.19) 0.72 (0.52–1.00) 0.08 0.83 (0.54–1.27) 0.40
SFA
Median, g/day 12.9 18.6 23.3 28.7 37.9
(% energy) (11) (12) (14) (15) (16)
Cases 207 198 198 188 183
HR (95% CI)
b 1.00 0.98 (0.78–1.23) 1.04 (0.79–1.36) 1.02 (0.73–1.44) 1.12 (0.69–1.81) 0.65 1.12 (0.84–1.49) 0.43
Breast cancer before the age 50 years
c
Total fat
Median, g/day 30.8 42.9 52.4 63.1 80.7
(% energy) (26) (29) (31) (32) (34)
Cases 78 83 82 99 90
HR (95% CI)
b 1.00 1.10 (0.79–1.52) 1.12 (0.78–1.62) 1.44 (0.95–2.16) 1.46 (0.87–2.47) 0.10 1.06 (0.96–1.18) 0.22
MUFA
Median, g/day 10.4 14.4 17.5 21.0 26.5
(% energy) (9) (10) (10) (11) (11)
Cases 76 84 93 84 95
HR (95% CI)
b 1.00 1.16 (0.81–1.66) 1.35 (0.88–2.06) 1.30 (0.76–2.21) 1.69 (0.81–3.51) 0.20 1.31 (0.63–2.73) 0.47
PUFA
Median, g/day 4.3 6.0 7.3 8.7 11.2
(% energy) (3.6) (4.0) (4.2) (4.4) (4.8)
Cases 78 80 94 97 83
HR (95% CI)
b 1.00 0.99 (0.71–1.38) 1.16 (0.82–1.66) 1.20 (0.80–1.78) 1.06 (0.64–1.75) 0.71 1.31 (0.79–2.46) 0.40
SFA
Median, g/day 12.9 18.6 23.3 28.7 37.9
(% energy) (11) (12) (14) (15) (17)
Cases 84 83 85 86 94
HR (95% CI)
b 1.00 0.93 (0.66–1.30) 0.90 (0.60–1.35) 0.88 (0.54–1.45) 0.93 (0.56–1.88) 0.86 0.81 (0.53–1.23) 0.32
Breast cancer after the age 50 years
d
Total fat
Median, g/day 30.8 42.8 52.4 63.0 80.2
(% energy) (27) (29) (31) (32) (34)
Cases 130 115 111 107 79
HR (95% CI)
b 1.00 0.91 (0.70–1.20) 0.93 (0.69–1.27) 0.93 (0.65–1.33) 0.76 (0.47–1.22) 0.34 1.01 (0.93–1.11) 0.77
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Epidemiologycompared to the first quintile for risk after age 50 years (HR: 0.55,
95% CI: 0.32–0.95) for ERþ tumours and: 0.52, 95% CI: 0.28–
0.98) for PRþ tumours. However, there was no significant
interaction between PUFA intake and age at diagnosis (o50 vs
X50) for ERþ tumours (P¼0.72) or PRþ tumours (P¼0.85).
No other statistically significant associations between total fat,
MUFA, PUFA and SFA intake and risk for ERþ,P R þ,E R   or
PR  tumours were found in the entire cohort or before or after age
50 years, irrespective of the models used (data not shown).
DISCUSSION
Our study did not find evidence for the entire cohort of an
association between total fat, MUFA, PUFA or SFA intakes and
breast cancer risk, or with ER or PR status. However, possible
differential effects of type of fats during premenopausal years were
suggested on risk above the age of 50 years. The lack of
associations with total fat, MUFA, PUFA or SFA is in agreement
with many earlier cohort studies (e.g. Kim et al, 2006).
However, statistically significant positive associations were
recently found for total fat both in a meta-analysis (Boyd et al,
2003) and a cohort study (Thiebaut et al, 2007); also for MUFA,
PUFA (Thiebaut et al, 2007) and for SFA in both these studies. All
this may reflect differences between the populations studied. For
example, Thiebaut et al studied women aged about 62 years at
entry and followed them for 5.2 years on average. Our women were
premenopausal at entry when their fat intake was assessed, and
were followed for 13 years on average. Further, Thiebaut’s women
were mostly overweight, while the average BMI in our study was
below 25kgm
 2. Finally, the intake ranges of total fat and subtypes
were narrower in our study and the food sources for the subtypes
slightly different.
The protective effect of MUFA in older women support is
consistent with the Swedish mammography cohort on postmeno-
pausal women (Wolk et al, 1998) but not with a nested case–
control (Wirfalt et al, 2002) and several cohort studies, which, with
some exceptions (Holmes et al, 1999; Voorrips et al, 2002), have
reported no or even a positive association with MUFA (Velie et al,
2000; Smith-Warner et al, 2001; Boyd et al, 2003; Cho et al, 2003;
Kim et al, 2006; Thiebaut et al, 2007). We also found a protective
effect of PUFA in older women, as in a few case–control studies
(Boyd et al, 2003) but not with any earlier prospective cohorts
(Boyd et al, 2003; Kim et al, 2006; Thiebaut et al, 2007). Our results
suggest that MUFA, PUFA and SFA might have different effects on
risk between breast cancer occurring before and after age 50 years,
for which no explanation is apparent; further work is indicated.
The most important limitation of our study was that dietary
intake was assessed only once, involving misclassification among
those who changed their dietary pattern during follow-up. Because
this is likely to be nondifferential, it would attenuate the strength
of any true association. However, there is a potential risk that the
degree of this misclassification increases over time because women
change their dietary habits. Thus, the longer the follow-up, the
more attenuated the association might be and we found some
evidence for this: thus among women over age 50 years, the risk
associated with MUFA (as a linear continuous variable) was 0.35
(95% CI: 0.13–0.97) for follow-up 0–10 years, but 1.00 (95% CI:
0.40–2.54) for longer follow-up; there was no significant interac-
tion between MUFA and follow-up time (P¼0.44).
Women with a high PUFA intake had a decreased risk of
developing ERþ and PRþ tumours after age 50 years, while no
other association with fat or its subtypes differed by ER or PR
status. An increased risk for ERþ/PRþ tumours with higher total
fat (Kushi et al, 1995) or those with animal fat intake (Cho et al,
2003) or those with no association has been reported (Kim et al,
2006). We cannot rule out that our findings are due to chance since
the numbers in each category (ERþ,P Rþ,P R   and ER ) was
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explained by PUFA containing relatively high levels of n-3 PUFA
if these, as reported, reduce the incidence of ER  breast tumours
(Hislop et al, 1988).
High fat intake may increase circulating oestrogens levels (Wu
et al, 1999) which then promote the growth of malignant
mammary cells. Saturated fat intake may increase risk through
multiple mechanisms, for example through their high levels of
hormone-like substances that were fed to cattle (Mitra et al, 2004),
by increasing the expression of genes promoting inflammatory
responses and inhibiting apoptosis, such as NF-kB (Lee et al, 2001)
or by increasing levels of cholesterol and low-density lipoprotein
which promote growth of malignant mammary cells (Le Guevel
and Pakdel, 2001). Since PUFA and MUFA intakes have been
reported to increase, reduce or have no effect on risk, invoking a
biological mechanism is premature.
Strengths of our study include its prospective design, large size
and complete follow-up. Cancer registration in Sweden is
obligatory, making the assessments of cases virtually complete.
Furthermore, we were able to adjust for several risk factors for
breast cancer. Misclassification of fat intakes due to measurement
error in the food frequency questionnaire is unavoidable, but given
the study design likely to be nondifferential, and thus attenuating
any true association. A recent study found a null association with
total fat intake using food frequency questionnaire data but a
positive association when a 7-day food diary was used (Bingham
et al, 2003). A positive finding may therefore depend on the dietary
method used.
Our study provides no evidence that total fat, MUFA, PUFA or
SFA is associated with overall breast cancer risk, but does not rule
out the possibility that types of fat may have differential effects on
breast cancer risk before and after age 50 years.
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